Atara Biotherapeutics to Present Phase 1 Study Update of ATA

Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021

Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021

financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Australia , California , United States , Montreal , Quebec , Canada , South San Francisco , Thousand Oaks , Douglasl Arnold , Eric Hyllengren , Monica Moreno , Jakob Dupont , Pascal Touchon , Atara Biotherapeutics Inc , Linkedin , Twitter , Neurorx Research , Nasdaq , Exchange Commission , Global Head Of Research , Montreal Neurological Institute , Securities Exchange , Mcgill University , Research In Multiple Sclerosis , European Committee For Treatment , European Committee , Multiple Sclerosis , Chief Medical Officer , Presentation Details , Conference Call , Chief Executive Officer , Executive Vice President , Global Head , Senior Vice President , Barr Virus , Securities Act , Securities Exchange Act , Southern California , Financial Condition ,